Aims. The aim of this study was to determine the rate of indocyanine green (ICG) staining of bone and
Aims. The aim of this study was to identify factors associated with five-year cancer-related mortality in patients with limb and trunk
Aims. Current literature suggests that survival outcomes and local recurrence rates of primary
Aims. The aim of this study was to evaluate the surgical management and outcome of patients with an acral
In our database of 7935 patients referred for investigation of a
Aims. Surgical site infection (SSI) after
Aims. Giant cell tumour of bone (GCTB) is a locally aggressive lesion that is difficult to treat as salvaging the joint can be associated with a high rate of local recurrence (LR). We evaluated the risk factors for tumour relapse after treatment of a GCTB of the limbs. Methods. A total of 354 consecutive patients with a GCTB underwent joint salvage by curettage and reconstruction with bone graft and/or cement or en bloc resection. Patient, tumour, and treatment factors were analyzed for their impact on LR. Patients treated with denosumab were excluded. Results. There were 53 LRs (15%) at a mean 30.5 months (5 to 116). LR was higher after curettage (18.4%) than after resection (4.6%; p = 0.008). Neither pathological fracture (p = 0.240), Campanacci grade (p = 0.734),
Aims. Time to treatment initiation (TTI) is generally defined as the time from the histological diagnosis of malignancy to the initiation of first definitive treatment. There is no consensus on the impact of TTI on the overall survival in patients with a
Aims. Urgent referral to a specialist centre for patients with a
Aims. The modified Glasgow Prognostic Score (mGPS) uses preoperative CRP and albumin to calculate a score from 0 to 2 (2 being associated with poor outcomes). mGPS is validated in multiple carcinomas. To date, its use in
Aims. Low-grade central osteosarcoma (LGCOS), a rare type of osteosarcoma, often has misleading radiological and pathological features that overlap with those of other bone tumours, thereby complicating diagnosis and treatment. We aimed to analyze the clinical, radiological, and pathological features of patients with LGCOS, with a focus on diagnosis, treatment, and outcomes. Methods. We retrospectively analyzed the medical records of 49 patients with LGCOS (Broder’s grade 1 to 2) treated between January 1985 and December 2017 in a single institute. We examined the presence of malignant features on imaging (periosteal reaction, cortical destruction,
Aims. Clear cell sarcoma (CCS) of
Aims. Patients with
Aims. While a centralized system for the care of patients with a sarcoma has been advocated for decades, regional variations in survival remain unclear. The aim of this study was to investigate regional variations in survival and the impact of national policies in patients with a
Aims. The aims of this study were to evaluate the long-term outcome
of surgery for bone or
We have investigated the oncological outcome of 63 patients with
We investigated whether our policy of routine re-excision of the tumour bed after an unplanned excision of a
We reviewed retrospectively 236 consecutive patients seen in our
We have investigated the significance of the method of treatment on the oncological and functional outcomes and on the complications in 184 patients with
We retrospectively reviewed 71 histopathologically-confirmed bone and